论文部分内容阅读
目的 研究 CEDU- Test对肿瘤患者检测的临床意义。方法 选肿瘤患者 43例 ,非肿瘤患者 12 9例 ,用CEDU - Test检测这些患者的空腹晨尿。结果 43例肿瘤患者空腹晨尿 CEDU- Test检测阳性 2 0例 (48.8% ) ,可疑阳性 5例 (9.3% ) ,阴性 18例 (41.8% ) ;非肿瘤患者空腹晨尿 CEDU- Test检测 ,阳性 10例 (7.7% ) ,可疑阳性 7例(5 .4% ) ,阴性 112例 (86 .8% )。两者对比有显著性差异 ,P<0 .0 1。CEDU- Test对肿瘤患者检测的敏感性为 2 4.4% ,特异性为 5 8.1%。结论 CEDU- Test可用于肿瘤的普查
Objective To study the clinical significance of CEDU-Test in the detection of cancer patients. Methods Forty-three cancer patients and 129 non-tumor patients were selected. The fasting morning urine of these patients was detected by CEDU-Test. Results Forty-three patients with fasting urine CEDU-Test were positive in 20 cases (48.8%), 5 cases were suspicious (9.3%), and 18 cases were negative (41.8%). Non-tumor patients were diagnosed as positive by CEDU-Test. 10 cases (7.7%), 7 cases (5.4%) were suspicious and 112 cases (86.8%) were negative. There was a significant difference between the two, P < 0.01. The CEDU-Test has a sensitivity of 24.4% and a specificity of 5.8% for tumor patients. Conclusion CEDU-Test can be used for tumor screening